72360-04-4

Usage

Uses

Used in Pharmaceutical Industry:
(5-methylfuran-2-yl)acetic acid is used as a building block for the synthesis of pharmaceutical compounds due to its unique structure and reactivity. Its presence in the molecular framework can potentially enhance the biological activity and pharmacological properties of the resulting drugs.
Used in Chemical Industry:
(5-methylfuran-2-yl)acetic acid is used as an intermediate in the synthesis of various chemical compounds, including agrochemicals, dyes, and other specialty chemicals. Its versatility in chemical reactions allows for the development of new and innovative products in the chemical market.
Used in Drug Development:
(5-methylfuran-2-yl)acetic acid is used as a potential therapeutic agent for the treatment of various diseases. Its unique structure may provide novel mechanisms of action and selectivity, leading to the development of new drugs with improved efficacy and safety profiles.
Used in Material Science:
(5-methylfuran-2-yl)acetic acid can be used in the development of new materials with specific properties, such as polymers with tailored characteristics for use in various industries, including electronics, automotive, and aerospace.

Upstream product

• 88662-93-5 5-methylfuran-2-ylacetonitrile 
• 857821-18-2 (5-methyl-[2]furyl)-glyoxylic acid 
• 88674-82-2 5-methylfurfuralrhodanine 
• 52157-57-0 5-methyl-2-(chloromethyl)furan 
• 620-02-0 5-Methylfurfural 
• 131543-46-9 Glyoxal 
• 217474-02-7 ethyl 6-hydroxy-2-hexynoate 
• 131271-33-5 ethyl 6-(tetrahydro-2H-pyran-2-yloxy)-2-hexynoate 
• 71948-59-9 ethyl 6-oxohex-2-ynoate 
• 5390-04-5 pent-1-yn-5-ol 
• 53906-90-4 ethyl 2-(5-methylfuran-2-yl)acetate 
• 1365393-13-0 ethyl 6-oxo-2-heptynoate 
• 1365393-10-7 ethyl 6-hydroxy-2-heptynoate 
• 62992-46-5 1-(tetrahydropyranyloxy)-4-pentyn 

Relevant academic research and scientific papers

Discovery of orally available 8-aza-5-thiaProstaglandin E1 analogs as highly selective EP4 agonists

Analogs 8-aza-16-aryl prostaglandin E1 (PGE1) and 8-aza-5-thia-16-arylPGE1 were synthesized and evaluated with respect to their subtype receptor affinity and EP4 agonist activity for the purposes of identifying sub-type- selective EP

Cyclic ketone derivatives and their medical applications

The present invention relates to cyclic ketones represented by the following formula and to drugs in which an effective component is such a cyclic ketone or a pharmacologically acceptable salt thereof.The cyclic ketones of the present invention encourage the production of blood platelets, leukocytes and erythrocytes, and can be employed in the prevention or treatment of cytopaenia brought about by cancer chemotherapy, radiotherapy or drug therapy, or by immunological abnormality, anaemia and the like.

Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands

PCT No. PCT/GB94/01936 Sec. 371 Date Mar. 12, 1996 Sec. 102(e) Date Mar. 12, 1996 PCT Filed Sep. 6, 1994 PCT Pub. No. WO95/07893 PCT Pub. Date Mar. 23, 1995A class of fused tricyclic heteroaromatic compounds of formula (I) as defined in claim 1 or a salt

LONG-ACTING CONTRACEPTIVE AGENTS: LEVONORGESTREL ESTERS OF UNSATURATED ACIDS

Esters of levonorgestrel (13β-ethyl-17α-ethynyl-17β-hydroxygon-4-en-3-one) with a variety of unsaturated carboxylic acids have been synthesized for evaluation as potential long-acting, injectable contraceptive agents.